Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Steinbach

Showing results (191-200 of 369) with videos related to

Pageof 37
Sort By:
International Journal of Molecular Sciences|May 19, 2018
Doxycycline Impairs Mitochondrial Function and Protects Human Glioma Cells from Hypoxia-Induced Cell Death: Implications of Using Tet-Inducible SystemsAnna-Luisa Luger, Benedikt Sauer, Nadja I Lorenz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2009
Long-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolomideMartin Glas, Caroline Happold, Johannes Rieger, et al.
Acta Neuropathologica Communications|August 22, 2018
Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastomaMichael W Ronellenfitsch, Pia S Zeiner, Michel Mittelbronn, et al.
European Journal of Neurology|October 13, 2021
Immune profile and radiological characteristics of progressive multifocal leukoencephalopathyPia S Zeiner, Leonhard Mann, Katharina Filipski, et al.
Molecular Cancer Therapeutics|October 26, 2016
Interference with the HSF1/HSP70/BAG3 Pathway Primes Glioma Cells to Matrix Detachment and BH3 Mimetic-Induced ApoptosisPatrick Antonietti, Benedikt Linder, Stephanie Hehlgans, et al.
Oncology|January 20, 2021
Gliomatosis Cerebri Growth Pattern: Association of Differential First-Line Treatment with Overall Survival in WHO Grade II and III GliomasIris Divé, Eike Steidl, Marlies Wagner, et al.
Neurology|January 26, 2006
Surviving glioblastoma for more than 5 years: the patient's perspectiveJ P Steinbach, H-P Blaicher, U Herrlinger, et al.
Journal of Neurochemistry|November 28, 2017
Suppression of oxidative phosphorylation confers resistance against bevacizumab in experimental gliomaJule A Eriksson, Christina Wanka, Michael C Burger, et al.
International Journal of Oncology|April 15, 2014
ERGO: a pilot study of ketogenic diet in recurrent glioblastomaJohannes Rieger, Oliver Bähr, Gabriele D Maurer, et al.
Neurology|March 30, 2022
Sex-Dependent Analysis of Temozolomide-Induced Myelosuppression and Effects on Survival in a Large Real-life Cohort of Patients With GliomaPia S Zeiner, Katharina Filipski, Natalie Filmann, et al.
Pageof 37

Showing results (191-200 of 369) with videos related to

Sort By:
Pageof 37
International Journal of Molecular Sciences|May 19, 2018
Doxycycline Impairs Mitochondrial Function and Protects Human Glioma Cells from Hypoxia-Induced Cell Death: Implications of Using Tet-Inducible SystemsAnna-Luisa Luger, Benedikt Sauer, Nadja I Lorenz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2009
Long-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolomideMartin Glas, Caroline Happold, Johannes Rieger, et al.
Acta Neuropathologica Communications|August 22, 2018
Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastomaMichael W Ronellenfitsch, Pia S Zeiner, Michel Mittelbronn, et al.
European Journal of Neurology|October 13, 2021
Immune profile and radiological characteristics of progressive multifocal leukoencephalopathyPia S Zeiner, Leonhard Mann, Katharina Filipski, et al.
Molecular Cancer Therapeutics|October 26, 2016
Interference with the HSF1/HSP70/BAG3 Pathway Primes Glioma Cells to Matrix Detachment and BH3 Mimetic-Induced ApoptosisPatrick Antonietti, Benedikt Linder, Stephanie Hehlgans, et al.
Oncology|January 20, 2021
Gliomatosis Cerebri Growth Pattern: Association of Differential First-Line Treatment with Overall Survival in WHO Grade II and III GliomasIris Divé, Eike Steidl, Marlies Wagner, et al.
Neurology|January 26, 2006
Surviving glioblastoma for more than 5 years: the patient's perspectiveJ P Steinbach, H-P Blaicher, U Herrlinger, et al.
Journal of Neurochemistry|November 28, 2017
Suppression of oxidative phosphorylation confers resistance against bevacizumab in experimental gliomaJule A Eriksson, Christina Wanka, Michael C Burger, et al.
International Journal of Oncology|April 15, 2014
ERGO: a pilot study of ketogenic diet in recurrent glioblastomaJohannes Rieger, Oliver Bähr, Gabriele D Maurer, et al.
Neurology|March 30, 2022
Sex-Dependent Analysis of Temozolomide-Induced Myelosuppression and Effects on Survival in a Large Real-life Cohort of Patients With GliomaPia S Zeiner, Katharina Filipski, Natalie Filmann, et al.
Pageof 37